Suppr超能文献

mLST8 对于冠状病毒复制是必需的,并通过 mTORC1 途径调节其复制。

mLST8 is essential for coronavirus replication and regulates its replication through the mTORC1 pathway.

机构信息

State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University , Wuhan, China.

Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production , Wuhan, China.

出版信息

mBio. 2023 Aug 31;14(4):e0089923. doi: 10.1128/mbio.00899-23. Epub 2023 Jun 28.

Abstract

Coronaviruses (CoVs), which pose a serious threat to human and animal health worldwide, need to hijack host factors to complete their replicative cycles. However, the current study of host factors involved in CoV replication remains unknown. Here, we identified a novel host factor, mammalian lethal with sec-13 protein 8 (mLST8), which is a common subunit of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), and is critical for CoV replication. Inhibitor and knockout (KO) experiments revealed that mTORC1, but not mTORC2, is essential for transmissible gastroenteritis virus replication. Furthermore, mLST8 KO reduced the phosphorylation of unc-51-like kinase 1 (ULK1), a factor downstream of the mTORC1 signaling pathway, and mechanistic studies revealed that decreased phosphorylation of the mTORC1 downstream factor ULK1 promoted the activation of autophagy, which is responsible for antiviral replication in mLST8 KO cells. Then, transmission electron microscopy indicated that both mLST8 KO and autophagy activator inhibited the formation of double-membrane vesicles in early viral replication. Finally, mLST8 KO and autophagy activator treatment could also inhibit the replication of other CoVs, indicating a conserved relationship between autophagy activation and CoV replication. In summary, our work reveals that mLST8 is a novel host regulator of CoV replication, which provides new insights into the mechanism of CoV replication and can facilitate the development of broad-spectrum antiviral drugs. IMPORTANCE CoVs are highly variable, and existing CoV vaccines are still limited in their ability to address mutations in CoVs. Therefore, the need to improve our understanding of the interaction of CoVs with the host during viral replication and to find targets for drugs against CoVs is urgent. Here, we found that a novel host factor, mLST8, is critical for CoV infection. Further studies showed that mLST8 KO inhibited the mTORC1 signaling pathway, and we found that autophagy activation downstream of mTORC1 was the main cause of antiviral replication in mLST8 KO cells. Autophagy activation impaired the formation of DMVs and inhibited early viral replication. These findings deepen our understanding of the CoV replication process and provide insights into potential therapeutic applications.

摘要

冠状病毒(CoVs)对全球人类和动物健康构成严重威胁,需要劫持宿主因子来完成其复制周期。然而,目前对参与 CoV 复制的宿主因子的研究仍不清楚。在这里,我们鉴定了一种新型宿主因子,哺乳动物致死性与 sec-13 蛋白 8(mLST8),它是 mTOR 复合物 1(mTORC1)和 mTOR 复合物 2(mTORC2)的常见亚基,对于 CoV 复制至关重要。抑制剂和敲除(KO)实验表明,mTORC1,而不是 mTORC2,对于传染性胃肠炎病毒的复制是必需的。此外,mLST8 KO 降低了 unc-51 样激酶 1(ULK1)的磷酸化,ULK1 是 mTORC1 信号通路的下游因子,机制研究表明,mTORC1 下游因子 ULK1 的磷酸化减少促进了自噬的激活,自噬在 mLST8 KO 细胞中负责抗病毒复制。然后,透射电子显微镜表明,mLST8 KO 和自噬激活剂均抑制早期病毒复制中双膜囊泡的形成。最后,mLST8 KO 和自噬激活剂处理也可以抑制其他 CoVs 的复制,这表明自噬激活与 CoV 复制之间存在保守关系。总之,我们的工作揭示了 mLST8 是 CoV 复制的新型宿主调节剂,为 CoV 复制机制提供了新的见解,并有助于开发广谱抗病毒药物。

重要性

CoVs 高度可变,现有的 CoV 疫苗在应对 CoV 突变方面的能力仍然有限。因此,迫切需要提高我们对 CoV 在病毒复制过程中与宿主相互作用的理解,并找到针对 CoV 的药物靶点。在这里,我们发现一种新型宿主因子 mLST8 对 CoV 感染至关重要。进一步的研究表明,mLST8 KO 抑制了 mTORC1 信号通路,我们发现 mTORC1 下游的自噬激活是 mLST8 KO 细胞中抗病毒复制的主要原因。自噬激活破坏了 DMVs 的形成并抑制了早期病毒复制。这些发现加深了我们对 CoV 复制过程的理解,并为潜在的治疗应用提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d2d/10470783/3a74bd5a02e9/mbio.00899-23.f001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验